Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Exercise/Conversion of 8,700 INO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 8,700 | n/a |
| May 18, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 4,771 | n/a |
| Mar 5, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 31,240 | n/a |
| Feb 27, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 5,010 | n/a |
| May 21, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 26,100 | n/a |
| May 16, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 4,771 | n/a |
| Feb 28, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 3,997 | n/a |
| May 16, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 4,771 | n/a |
| Feb 28, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 1,878 | n/a |
| May 17, 2023 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 171,756 | n/a |